Related Experiment Video

Updated: Jan 3, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K

Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes

Ken Inoue1

  • 1Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan. kinoue@ncnp.go.jp.

Advances in Experimental Medicine and Biology
|November 25, 2019
PubMed

Insights

Pelizaeus-Merzbacher disease (PMD) is a hypomyelinating leukodystrophy caused by mutations in the proteolipid protein 1 (PLP1) gene. This review explores how PLP1 mutations disrupt myelin development, leading to PMD and related disorders.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Pelizaeus-Merzbacher disease (PMD) is a group of hypomyelinating leukodystrophies.
  • It involves abnormal myelin development and maintenance in the central nervous system.
  • PMD pathogenesis is linked to the proteolipid protein 1 (PLP1) gene.

Purpose of the Study:

  • To review the historical context of PMD.
  • To elucidate the mechanisms by which PLP1 mutations cause PMD.
  • To discuss the spectrum of clinical phenotypes associated with PLP1 gene mutations.

Main Methods:

  • Literature review of historical and current research on PMD.
  • Analysis of molecular mechanisms of PLP1 mutations.
  • Correlation of genetic mutations with cellular pathologies and clinical outcomes.

Main Results:

  • PLP1 gene mutations are the primary cause of PMD.
  • Different mutations lead to varied cellular and molecular pathologies.
  • These variations result in a spectrum of clinical presentations.

Conclusions:

  • Understanding PLP1 mutation mechanisms is crucial for PMD research.
  • Further investigation can elucidate genotype-phenotype correlations.
  • This knowledge aids in understanding myelin disorders.
Keywords:
Genotype–phenotype correlationHypomyelinating leukodystrophiesMolecular mechanismPLP1 mutationsPelizaeus-Merzbacher disease

More Related Videos

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

1.1K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
663